The Latest Breaking News on Pharma

France issues warning over 300,000 unsafe condoms, at risk of bursting or leaking

France has recalled and flagged nearly 300,000 potentially unsafe condoms sold through pharmacies, shops and online marketplaces after laboratory tests found products that could burst or contain perforations, prompting authorities to warn consumers about possible health risks.

The Times of India · Aug 21

Prescription Drug Prices Fell 3.1 Percent Over the Year, but That Number Measures Less Than You Think

Prescription drug prices posted their steepest annual drop since 1963. Here is what the index actually measures and what it leaves out.

Medical Daily · Aug 20

Short Sellers Are Losing Big on Palantir — Here's the Data

Palantir Technologies Inc. (NASDAQ:PLTR) has become the single biggest pain point for short sellers in a market rally that is squeezing bears across the board, according to new data from S3 Partners.

Benzinga · Aug 19

Blood plasma giant's share price revives on growth path

An Aussie healthcare giant that put up its first annual loss as a listed group has staged a strong share price rebound as investors bet that the worst is over.

AAP · Aug 18

Justice Department watchdog to review DEA tactic that permitted deadly fentanyl to hit streets

The U.S. Justice Department's internal watchdog is reviewing a controversial DEA tactic in which agents permitted fentanyl to reach the streets to build cases against traffickers

The Independent UK · Aug 17

AstraZeneca ditches lung cancer treatment trial

The FTSE 100 firm stopped a stage volrustomig drug trial a month after halting a trial for a new heart disease treatment.

Evening Standard · Aug 17

Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'

China has pulled ahead of the United States in clinical drug development and supply chain, two of six domains measured in a June Cure Innovation Index survey, even as Big Pharma signs billion-dollar deals for Chinese-developed medicines.

Benzinga · Aug 13

Elizabeth Warren Says UnitedHealth, CVS Have Too Much Control Over US Healthcare—Now She Wants to Break Up the Vertical Integration

Sen. Elizabeth Warren (D-Mass) has criticized the vertical integration in the U.S. healthcare system, arguing that it leads to higher costs for patients and increased profits for large corporations.

Benzinga · Aug 10

Ozempic For $50 a Month? Amazon Pharmacy Rolls Out Cheap Weight-Loss Drugs for Medicare Patients

Amazon.com Inc.‘s (NASDAQ:AMZN) Amazon Pharmacy will offer eligible Medicare beneficiaries weight-loss drugs for $50 per month through a new federal program aimed at expanding access.

Benzinga · Aug 7

Soriot should explain the curious case of AstraZeneca’s non-deal

AstraZeneca’s rumoured takeover of Bristol Myers Squibb already looked weird, and was met with a lack of enthusiasm by shareholders

The Guardian - UK · Aug 5